Jin Medical International Ltd. Statistics
Share Statistics
Jin Medical International Ltd. has 156.55M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 156.55M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 37.82M |
| Failed to Deliver (FTD) Shares | 969 |
| FTD / Avg. Volume | 0.22% |
Short Selling Information
The latest short interest is 626.07K, so 0.4% of the outstanding shares have been sold short.
| Short Interest | 626.07K |
| Short % of Shares Out | 0.4% |
| Short % of Float | 1.66% |
| Short Ratio (days to cover) | 1.92 |
Valuation Ratios
The PE ratio is 59 and the forward PE ratio is null.
| PE Ratio | 59 |
| Forward PE | null |
| PS Ratio | 8.57 |
| Forward PS | null |
| PB Ratio | 7.08 |
| P/FCF Ratio | 56.75 |
| PEG Ratio | n/a |
Enterprise Valuation
Jin Medical International Ltd. has an Enterprise Value (EV) of 166.99M.
| EV / Earnings | 58.02 |
| EV / Sales | 8.42 |
| EV / EBITDA | 53.99 |
| EV / EBIT | 58.24 |
| EV / FCF | 55.81 |
Financial Position
The company has a current ratio of 3.49, with a Debt / Equity ratio of 0.17.
| Current Ratio | 3.49 |
| Quick Ratio | 2.83 |
| Debt / Equity | 0.17 |
| Total Debt / Capitalization | 14.64 |
| Cash Flow / Debt | 0.76 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.12% and return on capital (ROIC) is 9.12%.
| Return on Equity (ROE) | 0.12% |
| Return on Assets (ROA) | 0.09% |
| Return on Capital (ROIC) | 9.12% |
| Revenue Per Employee | 80.90K |
| Profits Per Employee | 11.75K |
| Employee Count | 245 |
| Asset Turnover | 0.6 |
| Inventory Turnover | 2.23 |
Taxes
| Income Tax | 343.71K |
| Effective Tax Rate | 0.11 |
Stock Price Statistics
The stock price has increased by -82.97% in the last 52 weeks. The beta is 20.8, so Jin Medical International Ltd.'s price volatility has been higher than the market average.
| Beta | 20.8 |
| 52-Week Price Change | -82.97% |
| 50-Day Moving Average | 1.26 |
| 200-Day Moving Average | 2.59 |
| Relative Strength Index (RSI) | 50.24 |
| Average Volume (20 Days) | 440.97K |
Income Statement
In the last 12 months, Jin Medical International Ltd. had revenue of 19.82M and earned 2.88M in profits. Earnings per share was 0.02.
| Revenue | 19.82M |
| Gross Profit | 6.78M |
| Operating Income | 2.87M |
| Net Income | 2.88M |
| EBITDA | 3.09M |
| EBIT | 2.87M |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 6.93M in cash and 4.11M in debt, giving a net cash position of 2.82M.
| Cash & Cash Equivalents | 6.93M |
| Total Debt | 4.11M |
| Net Cash | 2.82M |
| Retained Earnings | 16.93M |
| Total Assets | 41.16M |
| Working Capital | 23.35M |
Cash Flow
In the last 12 months, operating cash flow was 3.11M and capital expenditures -113.94K, giving a free cash flow of 2.99M.
| Operating Cash Flow | 3.11M |
| Capital Expenditures | -113.94K |
| Free Cash Flow | 2.99M |
| FCF Per Share | 0.02 |
Margins
Gross margin is 3.42K%, with operating and profit margins of 1.45K% and 1.45K%.
| Gross Margin | 3.42K% |
| Operating Margin | 1.45K% |
| Pretax Margin | 1.63K% |
| Profit Margin | 1.45K% |
| EBITDA Margin | 15.61% |
| EBIT Margin | 14.47% |
| FCF Margin | 15.1% |
Dividends & Yields
ZJYL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 1.96% |
| FCF Yield | 1.86% |
Analyst Forecast
Currently there are no analyst rating for ZJYL.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Feb 8, 2024. It was a forward split with a ratio of 20:1.
| Last Split Date | Feb 8, 2024 |
| Split Type | forward |
| Split Ratio | 20:1 |
Scores
| Altman Z-Score | 8.37 |
| Piotroski F-Score | 4 |